Sources, Transport, Exposure & Effects of PFAS (STEEP) Center - RENEWAL
来源、运输、暴露
基本信息
- 批准号:10704006
- 负责人:
- 金额:$ 153.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccountingAddressAdverse effectsAffectAirAreaAtmosphereAwarenessBiological MarkersBreast FeedingChemicalsChildCodsCollaborationsCommunicationCommunication ToolsCommunitiesComplexCoronavirusDataData AnalysesDelawareDependenceDetectionDevelopmentDiffuseDustEducationEndocrineEndocrine disruptionEnvironmental Engineering technologyEnvironmental ScienceExcretory functionExposure toFAIR principlesFaeroe IslandsFeedbackFilmFishesFoodFosteringFundingGoalsGreat Lakes RegionGrowthHealthHumanHuman MilkImmunologic MarkersInfantInterventionJointsKnowledgeLaboratoriesLinkMeasurementMeasuresMentorsMentorshipMetabolicMetabolismMilkModelingMolecularOutcomePaperPathway interactionsPoliciesPrevention strategyPrivatizationProcessPublic HealthResearchResearch Project GrantsResourcesRhode IslandRiskRisk AssessmentRodentSafetyScienceSerumShellfishSignal Recognition ParticleSiteSoilSourceSuperfundTimeTissuesToxicokineticsTrainingTranslatingTranslational ResearchTribesUncertaintyUnited States National Institutes of HealthUniversitiesVaccinationVulnerable PopulationsWampanoagWaterWorkabsorptionage relatedanalytical toolaqueousbasebioaccumulationcohesioncohortcommunity engagementdata managementdrinking watereffectiveness evaluationenvironmental chemistryequity, diversity, and inclusionexperienceexposed human populationexposure pathwayground waterhigh schoolimmunotoxicityimprovedindoor airinnovationinsightnoveloutreachoxidationpollutantpredictive modelingpreventprogramsremediationresponsesuperfund sitetooluptake
项目摘要
PROJECT SUMMARY/ABSTRACT – OVERALL
PFAS have emerged as national priority pollutants, and more than 2000 sites contaminated by PFAS have been
identified across the U.S., including 180 EPA-identified Superfund sites. Elevated human exposures to PFAS
have been associated with adverse health outcomes, including metabolic disruption, immunotoxicity, and
endocrine disruption, although exposure-dependence and individual vulnerability need to be better understood.
STEEP II builds on the successful collaborative it established within the first STEEP SRP Center (STEEP I) to
further advance the science, training, engagement and outreach in support of SRP mandates. STEEP II will
continue to collaborate with the RI and MA state and federal agencies, and will expand its reach to work with DE,
ME, NJ, and MI state agencies in support of their needs for knowledge on PFAS. The environmental engineering
and chemistry projects will focus on the transport and transformation of PFAS precursors, as well as legacy,
novel, and total PFAS. Novel detection tools will be developed and used to support remediation of PFAS-
contaminated groundwater, the atmospheric transport and fate of PFAS, and to predict bioaccumulation of PFAS
relative to modeling predictions. The Center will build on its leading research on the critical effects of PFAS in
children, with a focus on immunotoxicity and metabolism. Given the public health importance of breastfeeding,
STEEP II will focus on understanding cellular mechanisms that dictate PFAS uptake and elimination into milk
and accumulation in the infant, thereby advancing understanding of toxicokinetic mechanisms and potentials for
preventing PFAS from reaching human milk. STEEP II research projects, working with the Community
Engagement Core (CEC) and the Data Management and Analysis Core (DMAC), will perform a thorough human
exposure assessment for PFAS and risk assessment. STEEP trainees and mentors will remain key to the
ongoing growth as a unified Center, via cross-cutting collaboration fostered by the Research Experience and
Training Coordination Core (RETCC), and joint mentorship. STEEP II will include an additional focus on Diversity,
Equity, and Inclusion (DEI) training for trainees and mentors alike. The STEEP II goals will address the following
Specific Aims:
Specific Aim 1: Assess the distribution, transformations, and bioaccumulation of PFAS
Specific Aim 2: Investigate the processes affecting PFAS distribution and uptake and assess critical
adverse effects in humans
Specific Aim 3: Engage new and established stakeholders across multiple sites
Specific Aim 4: Integrate STEEP internally and execute effective outreach and collaboration with
stakeholders
项目摘要/摘要 - 总体
PFA已成为国家优先污染物,2000多个受PFA污染的地点已经存在
在美国各地确定,包括180个EPA识别的超级基金网站。人类对PFA的暴露率高
与不良健康结果有关,包括代谢中断,免疫毒性和
尽管需要更好地理解暴露依赖性和个人脆弱性,但内分泌干扰仍需要更好地理解。
陡峭的II建立在它在第一个陡峭的SRP中心(陡峭I)中建立的成功合作基础上
进一步推进了支持SRP任务的科学,培训,参与和宣传。陡峭的II
继续与RI和MA州和联邦机构合作,并将扩大其与DE合作的影响力
我,新泽西州和MI州机构支持他们对PFA的知识需求。环境工程
化学项目将着重于PFA的前体的运输和转型,以及遗产,
小说和全部PFA。新型检测工具将被开发并用于支持PFAS-的补救
受污染的地下水,PFA的大气传输和命运,并预测PFA的生物蓄积
相对于建模预测。该中心将基于对PFA在PFA中的关键影响的主要研究基础
儿童,专注于免疫毒性和代谢。考虑到公共健康的母乳喂养重要性,
陡峭的II将专注于理解决定PFA摄取和消除牛奶的细胞机制
并在婴儿中积累,从而促进对毒物机制和潜力的理解
防止PFA到达人奶。陡峭的II研究项目,与社区合作
参与核心(CEC)和数据管理和分析核心(DMAC)将进行彻底的人类
PFA和风险评估的暴露评估。陡峭的学员和导师将仍然是
作为一个统一中心的持续增长,通过研究经验培养的横切协作和
培训协调核心(RETCC)和联合心态。陡峭的II将包括对多样性的额外关注,
对学员和导师的公平和包容(DEI)培训。陡峭的II目标将解决以下
具体目的:
特定目的1:评估PFA的分布,转换和生物积累
特定目的2:调查影响PFA分布以及摄取和评估关键的过程
人类的不利影响
特定目的3:与多个站点的新利益相关者互动
特定目标4:内部陡峭的陡峭并执行有效的外展和合作
利益相关者
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rainer Lohmann其他文献
Rainer Lohmann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rainer Lohmann', 18)}}的其他基金
5P42ES027706 Sources, Transport, Exposure, and Effects of PFASs (STEEP) SRP
5P42ES027706 PFAS (STEEP) SRP 的来源、传输、暴露和影响
- 批准号:
10381901 - 财政年份:2021
- 资助金额:
$ 153.43万 - 项目类别:
P42ES027706 URI Sources, Transport, Exposure, and Effects of PFAS (STEEP) SRP
P42ES027706 PFAS (STEEP) SRP 的 URI 来源、传输、暴露和影响
- 批准号:
10399005 - 财政年份:2021
- 资助金额:
$ 153.43万 - 项目类别:
5P42ES027706 Sources, Transport, Exposure, and Effects of PFASs (STEEP) SRP
5P42ES027706 PFAS (STEEP) SRP 的来源、传输、暴露和影响
- 批准号:
10380984 - 财政年份:2021
- 资助金额:
$ 153.43万 - 项目类别:
Sources, Transport, Exposure and Effects of PFASs (STEEP)
PFAS 的来源、传输、暴露和影响 (STEEP)
- 批准号:
10205254 - 财政年份:2017
- 资助金额:
$ 153.43万 - 项目类别:
Sources, Transport, Exposure and Effects of PFASs (STEEP)
PFAS 的来源、传输、暴露和影响 (STEEP)
- 批准号:
9904663 - 财政年份:2017
- 资助金额:
$ 153.43万 - 项目类别:
Sources, Transport, Exposure and Effects of PFASs (STEEP)
PFAS 的来源、传输、暴露和影响 (STEEP)
- 批准号:
10205263 - 财政年份:2017
- 资助金额:
$ 153.43万 - 项目类别:
Sources, Transport, Exposure & Effects of PFAS (STEEP) Center - RENEWAL
来源、运输、暴露
- 批准号:
10352509 - 财政年份:2017
- 资助金额:
$ 153.43万 - 项目类别:
Passive samplers in support of Remediation, Detection and Bioaccumulation of PFAS
支持 PFAS 修复、检测和生物累积的被动采样器
- 批准号:
10352513 - 财政年份:2017
- 资助金额:
$ 153.43万 - 项目类别:
Passive samplers in support of Remediation, Detection and Bioaccumulation of PFAS
支持 PFAS 修复、检测和生物累积的被动采样器
- 批准号:
10704017 - 财政年份:2017
- 资助金额:
$ 153.43万 - 项目类别:
Sources, Transport, Exposure & Effects of PFAS (STEEP) Center - RENEWAL
来源、运输、暴露
- 批准号:
10866862 - 财政年份:2017
- 资助金额:
$ 153.43万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Reproductive history and later-life brain health: The Bogalusa Heart Study
生殖史和晚年大脑健康:Bogalusa 心脏研究
- 批准号:
10736169 - 财政年份:2023
- 资助金额:
$ 153.43万 - 项目类别:
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
米托醌/甲磺酸米托喹诺作为 Covid-19 的口服且安全的暴露后预防
- 批准号:
10727092 - 财政年份:2023
- 资助金额:
$ 153.43万 - 项目类别:
Gabapentinoid/opioid mixtures: abuse and toxicity
加巴喷丁/阿片类混合物:滥用和毒性
- 批准号:
10639396 - 财政年份:2023
- 资助金额:
$ 153.43万 - 项目类别:
Physical Frailty and Symptom Monitoring and Management Behaviors in Heart Failure (PRISM-HF)
心力衰竭的身体虚弱和症状监测和管理行为 (PRISM-HF)
- 批准号:
10740609 - 财政年份:2023
- 资助金额:
$ 153.43万 - 项目类别:
Class II Human Leukocyte Antigen biologics for antibody-mediated graft rejection.
用于抗体介导的移植物排斥反应的 II 类人类白细胞抗原生物制剂。
- 批准号:
10598931 - 财政年份:2023
- 资助金额:
$ 153.43万 - 项目类别: